Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Exanthema × Alpelisib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Ovarian Neoplasms 2 Hereditary Sensory and Autonomic Neuropathies 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Hyperglycemia 1 Exanthema 1 Advanced or Metastatic ER+ Breast Cancer 1 Advanced Breast Cancer 1

Interventions

benralizumab 1 Sirolimus 1 Gels 1 Fulvestrant 1 Fibroblast Growth Factor 7 1 Dapsone 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05966584 2024-08-29

A Study to Prevent Rash in People Starting Alpelisib for the Treatment of Breast Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Terminated

1 enrolled 5 charts

Breast Neoplasms, Exanthema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡